Georgios Tsivgoulis1, Theodoros N Sergentanis2, Andrew Chan3, Konstantinos Voumvourakis4, Nikos Triantafyllou5, Theodora Psaltopoulou2, Ralf Gold3, Christos Krogias3. 1. Second Department of Neurology, 'Attikon' Hospital, School of Medicine, University of Athens, Iras 39, Gerakas Attikis, 15344, Athens, Greece and International Clinical Research Center, St Anne's University Hospital Brno, Brno, Czech Republic. 2. Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, University of Athens, Athens, Greece. 3. Department of Neurology, Ruhr University, St Josef-Hospital, Bochum, Germany. 4. Second Department of Neurology, 'Attikon' Hospital, School of Medicine, University of Athens, Athens, Greece. 5. First Department of Neurology, 'Eginition' Hospital, School of Medicine, University of Athens, Athens, Greece.
Abstract
OBJECTIVES: Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case-control studies investigates the association of CCSVI with MS. METHODS: Through Medline, EMBASE and Cochrane database searches, case-control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. RESULTS: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44-20.31; p < 0.001) with considerable heterogeneity across studies (I (2) = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62-2.93; p = 0.453) without any heterogeneity (I (2) = 0%). CONCLUSION: There is considerable heterogeneity across different case-control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.
OBJECTIVES:Chronic cerebrospinal venous insufficiency (CCSVI) has recently been implicated in the pathogenesis of multiple sclerosis (MS). This comprehensive meta-analysis of case-control studies investigates the association of CCSVI with MS. METHODS: Through Medline, EMBASE and Cochrane database searches, case-control ultrasound studies comparing CCSVI frequency among patients with MS and healthy controls were identified. RESULTS: We identified 19 eligible studies including 1250 patients with MS and 899 healthy controls. The pooled analysis showed that CCSVI was associated with MS [odds ratio (OR) 8.35; 95% confidence interval (CI) 3.44-20.31; p < 0.001) with considerable heterogeneity across studies (I (2) = 80.1%). This association was substantially attenuated in sensitivity analyses excluding studies that were carried out by the group that originally described CCSVI, included investigators who had also been involved in publications advocating endovascular procedures for CCSVI treatment, or were conducted in Italy. Our most conservative sensitivity analysis combining different exclusion criteria yielded no association of CCSVI with MS (OR 1.35; 95% CI 0.62-2.93; p = 0.453) without any heterogeneity (I (2) = 0%). CONCLUSION: There is considerable heterogeneity across different case-control studies evaluating the association of CCSVI and MS. The greatest factor contributing to this heterogeneity appears to be the involvement of investigators in other publications supporting endovascular procedures as a novel MS treatment.
Authors: Claudio Baracchini; José M Valdueza; Massimo Del Sette; Galina Baltgaile; Eva Bartels; Natan M Bornstein; Juergen Klingelhoefer; Carlos Molina; Kurt Niederkorn; Mario Siebler; Matthias Sturzenegger; Bernd E Ringelstein; David Russell; Laszlo Csiba Journal: J Neurol Date: 2012-05-31 Impact factor: 4.849
Authors: G Tsivgoulis; M Mantatzis; C Bogiatzi; K Vadikolias; K Voumvourakis; P Prassopoulos; C Piperidou; I Heliopoulos Journal: Neurology Date: 2011-08-17 Impact factor: 9.910
Authors: T Ludyga; M Kazibudzki; M Simka; M Hartel; M Swierad; J Piegza; P Latacz; L Sedlak; M Tochowicz Journal: Phlebology Date: 2010-12 Impact factor: 1.740
Authors: Fiona Costello; Jayesh Modi; David Lautner; Deepak Bhayana; James N Scott; W Jeptha Davenport; Jessie Trufyn; Richard Frayne; Viesha A Ciura; Mayank Goyal; Jean Mah; Michael D Hill Journal: CMAJ Date: 2014-06-02 Impact factor: 8.262
Authors: Eric M Schrauben; Sarah Kohn; Jacob Macdonald; Kevin M Johnson; Mark Kliewer; Sam Frost; John O Fleming; Oliver Wieben; Aaron Field Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200